KARI JOYNER: Open Payments
NPI 1225454432 · MCBEE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,429 in 83 payments from 23 companies in 2025. Trend: 2023 $1,512 · 2024 $1,579 · 2025 $1,429
Food & beverage: $1,429
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $305 |
| ABBVIE INC. | 15 | $182 |
| PFIZER INC. | 8 | $150 |
| AstraZeneca Pharmaceuticals LP | 6 | $92 |
| Amgen Inc. | 5 | $91 |
| Dexcom, Inc. | 3 | $66 |
| Abbott Laboratories | 4 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| Astellas Pharma US Inc | 2 | $41 |
Products named: NURTEC ODT, Ozempic, OTEZLA, Wegovy, VRAYLAR, Dexcom G6 Transmitter, UBRELVY, AIRSUPRA.
Industry payments across SC — which companies pay providers there.
